Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects

Keyphrases

• Mantle Cell Lymphoma 100%
• Ibrutinib 100%
• Ibrutinib Resistance 100%
• Acquired Resistance 50%
• B-cell Receptor Signaling 50%
• Clinical Trials 25%
• Molecular Mechanism 25%
• Molecular Events 25%
• B-cell Lymphoma 25%
• Lymphoma Patients 25%
• Primary Resistance 25%
• Lymphoproliferative Disorders 25%
• Primary Drug Resistance 25%
• Bruton's Tyrosine Kinase 25%

Medicine and Dentistry

• Mantle Cell Lymphoma 100%
• Ibrutinib 100%
• B Lymphocyte Receptor 28%
• Signal Transduction 14%
• Clinical Trial 14%
• Drug Resistance 14%
• Cyclic AMP Dependent Protein Kinase 14%
• B-Cell Lymphoma 14%
• Lymphoproliferative Disease 14%
• Bruton Tyrosine Kinase 14%
• Cell Signaling Pathway 14%